| « Previous month | Next month » |
Bio-Rad has published several application notes describing the use of its Profinity eXact protein expression system to obtain tag-free native proteins from a cell lysate in less than an hour.
In response to high customer demand, leading automated chemistry systems manufacturer Syrris is now offering to build custom-made laboratory reactor systems designed to meet individual customer needs.
Robert Friel’s tenure as CEO of PerkinElmer continued its strong start with the firm reporting a 21 per cent increase in second quarter revenues compared to the same period last year.
Affymetrix slumped to an operating loss in the second quarter of 2008, reporting flat revenues and blaming a 30 per cent reduction in sales to the pharmaceutical sector.
US physicists have built the world's most sensitive 'nanomechanical mass spectrometer' that can accurately determine the mass of objects lighter than a single gold atom.
Thermo Fisher Scientific has followed up its acquisition of Open Biosystems with the purchase of antibody experts Affinity BioReagents to further bolster its protein research offering.
UK researchers have used the ReNcell VM stem cell line, licensed by Millipore from UK stem cell therapy experts ReNeuron, to model neural degeneration observed in Parkinson's disease.
With fears of a global recession riding on the back of the credit crisis, many laboratory suppliers have managed to weather the storm and still achieve double digit sales growth in the second quarter of 2008.
UK-headquartered ESA Biosciences has unveiled a new system for the identification of low levels organic impurities during the production of active pharmaceutical ingredients (API).
Laboratory services and diagnostics company Medtox Scientific has posted a healthy hike in operating profits for the second quarter, despite a challenging operating environment that pegged back sales growth.
UK-headquartered ESA Biosciences has unveiled a new technique for the identification of low levels organic impurities during the production of active pharmaceutical ingredients (API).
Caliper Life Sciences has launched two new microfluidic-based electrophoresis instruments designed to address the separation needs of proteomic and genomic researchers.
Scientists have completed the most comprehensive mammalian transcriptome analysis to date and believe the results should further our understanding of disease pathways.
Thermo Fisher Scientific has integrated Genedata's Expressionist software with its high resolution mass spectrometry (MS) offering to enable high-throughput metabolomics data processing.
Nanopoint has launched the 'world's most advanced' on-microscope cell containment device that offers complete environmental control for time-lapse cell imaging applications.
Bio-Rad has launched a new web-based search tool to give researchers easier access to its validated siLentMer gene silencing product line, which offers up to twice the silencing longevity.
Pharmaceutical companies in the developed world have already shifted substantial manufacturing and clinical trial work to emerging economies such as China and India, but a new study suggest they are increasingly counting on these countries for advanced research and development services as well.
The US Food and Drug Administration (FDA) is launching a quality-by-design (QbD) pilot programme for biotechnology submissions.
PerkinElmer has created the ViaCord Research Institute (VRI) to investigate new uses of stem cells derived from umbilical cord blood.
Agilent has continued its summer spending spree with the acquisition of US-based Particle Sizing Systems that will further bolster the firm's Materials Science Services Unit (MSSU).
Electron microscopy expert FEI has launched a new range of scanning electron microscopes (SEM) that enables sub-nanometre 3D surface imaging.
Sangamo Biosciences and Sigma-Aldrich have licensed their zinc finger nuclease (ZFN) technology to Roche to enable the pharma giant to develop cell lines and transgenic animals.
Researchers from Germany's Fraunhofer Institute are using Affymetrix' assay technology to develop tests that detect drug induced liver injury (DILI).
MDS Analytical Technologies has followed its acquisition of Molecular Devices last year by snapping up high content screening (HCS) experts Blueshift for $15m (€9.45m).
High throughput (HT) screening expert Cisbio Bioassays and the Institute of Functional Genomics (IGF), Montpellier, have developed a method of analysing the receptor complexes that govern cell-cell communications.
In this week's review of activity within the preclinical research services arena, news has emerged involving Charles River Laboratories, Galapagos and AstraZeneca.
Agilent Technologies has continued its push into the materials science market with the acquisition of nanoindentation instrument manufacturer Nano Instruments.
Laboratory industry heavyweight, Thermo Fisher Scientific has acquired shRNA expert Open Biosystems to expand its gene silencing offering.
Dutch sample and assay expert, Qiagen has bought Australia-based Corbett Life Science Pty in a deal that could be worth up to $135m (€86m).
| « Previous month | Next month » |